34
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Obesity is not associated with contrast nephropathy

, , &
Pages 213-217 | Published online: 05 May 2010

References

  • LautinEMFreemanNJSchoenfeldAHRadiocontrast-associated renal dysfunction: incidence and risk factorsAm J Roentgenol199115749582048539
  • DetrenisSMeschiMMusiniSSavazziGLights and shadows on the pathogenesis of contrast-induced nephropathy: state of the artNephrol Dial Transplant2005201542155016033768
  • PerssonPBHansellPLissPPathophysiology of contrast medium-induced nephropathyKidney Int200568142215954892
  • HeymanSNRosenbergerCRosenSRegional alterations in renal haemodynamics and oxygenation: a role in contrast medium-induced nephropathyNephrol Dial Transplant200520 Suppl 1i6i1115705946
  • AgmonYPelegHGreenfieldZRosenSBrezisMNitric oxide and prostanoids protect the renal outer medulla from radiocontrast toxicity in the ratJ Clin Invest199494106910758083347
  • WeisbergLSKurnikPBKurnikBRRadiocontrast-induced nephropathy in humans. Role of renal vasoconstrictionKidney Int199241140814151614056
  • CantleyLGSpokesKClarkBAMcMahonEGCarterJEpsteinFHRole of endothelin and prostaglandins in radiocontrast-induced renal artery constrictionKidney Int199344121712238301922
  • RussoDMinutoloRCianciarusoBMemoliBConteGDe NicolaLEarly effects of contrast media on renal hemodynamics and tubular function in chronic renal failureJ Am Soc Nephrol19956145114588589322
  • McCulloughPAAdamABeckerCRRisk prediction of contrast-induced nephropathyAm J Cardiol2006986A27K36K
  • ShoelsonSEHerreroLNaazAObesity, inflammation, and insulin resistanceGastroenterology20071322169218017498510
  • KnightSFImigJDObesity, insulin resistance, and renal functionMicrocirculation2007144–534936217613807
  • CalabroPYehETObesity, inflammation, and vascular disease: the role of the adipose tissue as an endocrine organSubcell Biochem200742639117612046
  • MilneGLMusiekESMorrowJDF2-isoprostanes as markers of oxidative stress in vivo: an overviewBiomarkers2005Suppl 1S10S2316298907
  • DietrichMBlockGHudesMAntioxidant supplementation decreases lipid peroxidation biomarker F2-isoprostanes in plasma of smokersCancer Epidemiol Biomarkers Prev20021171311815395
  • DragerLAndradeLBarros de ToledoJRenal effects of N-acetylcysteine in patients at risk for contrast nephropathy: decrease in oxidant stress-mediated renal tubular injuryNephrol Dial Transplant2004191803180715128882
  • ChagnacAHermanMZingermanBObesity-induced glomerular hyperfiltration: its involvement in the pathogenesis of tubular sodium reabsorptionNephrol Dial Transplant200823123946395218622024
  • CirilloMAnastasioPDe SantoNGRelationship of gender, age and body mass index to errors in predicted kidney functionNephrol Dial Transplant2005201791179815998649
  • VerhaveJCFeslerPRibsteinJCailarGMimranAEstimation of renal function in subjects with normal serum creatinine levels: influence of age and body mass indexAm J Kidney Dis20054623324116112041
  • Blanco-ColioLTunonJMartin-VenturaJEgidoJAnti-inflammatory and immunomodulatory effects of statinsKindey Int2003631223
  • Bouzas-MosqueraAVazquez-RodriguezJMCalvino-SantosRVázquez-GonzálezNCastro-BeirasAStatin therapy and contrast-induced nephropathy after primary angioplastyInt J Cardiol200913443043118466989
  • GonzalesDANorsworthyKJKernSJA meta-analysis of N-acetylcysteine in contrast-induced nephropathy: unsupervised clustering to resolve heterogeneityBMC Med200753218001477